3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Stomatitis
2
Neoplasms
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Radiation Induced Xerostomia
1
Radiation Fibrosis Syndrome
1
Mouth Neoplasms
1
Lymphedema
1
Hematologic Neoplasms
1
Hand-Foot Syndrome
1
Graft vs Host Disease
1
Cognitive Dysfunction
1
Breast Cancer Lymphedema
1
Interventions
Magnetic Resonance Spectroscopy
12
Specimen Handling
10
Cisplatin
7
Radiation
6
pembrolizumab
5
Platinum
5
Biopsy
5
1,2-diaminocyclohexaneplatinum II citrate
5
Sentinel Lymph Node Biopsy
4
Drug Therapy
4
cemiplimab
3
X-Rays
3
Ultrasonography
3
Standard of Care
3
Radiotherapy, Intensity-Modulated
3
Radiotherapy
3
Cetuximab
3
Carboplatin
3
Taxes
2
Surgical Procedures, Operative
2
Practice Guidelines as Topic
2
Photons
2
Paclitaxel
2
Interviews as Topic
2
trastuzumab deruxtecan
1
toripalimab
1
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
sacituzumab govitecan
1
merphos
1
ipatasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Mouth Neoplasms
×
Low-Level Light Therapy
×
Clear all
NCT07387978
2026-02-04
PBM
Peter MacCallum Cancer Centre, Australia
Phase NA
Recruiting
30 enrolled